Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 66,588 shares at $25.77 ($1.7M) on 2012-12-06, disclosed to the SEC on 2012-12-10.
Open-market sale of $1.7M SGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.77 | 30,000 | $773K | 45.1% |
| 2 | $25.77 | 30,000 | $773K | 45.1% |
| 3 | $25.75 | 1,250 | $32K | 1.9% |
| 4 | $25.75 | 5,338 | $137K | 8.0% |
| Total | $25.77 avg | 66,588 | $1.7M | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |
| SGEN | SELL | 2012-12-03 | $1.0M | — | Filing → |